Understanding Heart Rhythm Problems in Diabetes
Leukotriene B4 Regulation in Heart
This project looks at a specific molecule called leukotriene B4 to understand why people with type 2 diabetes are at higher risk for dangerous heart rhythms.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State Higher Education System--University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11101144 on NIH RePORTER |
What this research studies
Patients with type 2 diabetes face a higher risk of sudden cardiac death due to serious heart rhythm problems. We are exploring why this happens by focusing on a molecule called leukotriene B4, which is often found at higher levels in people with diabetes. Our work suggests that this molecule might make heart cells more prone to dangerous electrical activity. We are also looking into existing medications that block leukotriene B4, which have shown promise in protecting the heart.
Who could benefit from this research
Good fit: This research is relevant for patients with type 2 diabetes who are at risk for or experience heart rhythm abnormalities.
Not a fit: Patients without type 2 diabetes or heart rhythm issues related to diabetes would likely not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to identify patients with type 2 diabetes at high risk for sudden cardiac death and develop new treatments to prevent life-threatening heart arrhythmias.
How similar studies have performed: Previous research has shown that blocking leukotriene B4 can reduce metabolic defects and prevent arrhythmias in some contexts, suggesting a promising direction for this work.
Where this research is happening
Salt Lake City, United States
- Utah State Higher Education System--University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Aromolaran, Ademuyiwa — Utah State Higher Education System--University of Utah
- Study coordinator: Aromolaran, Ademuyiwa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.